Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOXJean‐François Emile, Yves Humblet, Josep Tabernero et al.|European Journal of Cancer|2017Cited by 47
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial datasetJosef Thaler, Mohamed-Ayman Zawadi, Richard Greil et al.|Annals of Oncology|2015Cited by 4